Literature DB >> 24430701

Ambulatory blood pressure monitoring for risk stratification in obese and non-obese subjects from 10 populations.

T W Hansen1, L Thijs2, Y Li3, J Boggia4, Y Liu2, K Asayama5, M Kikuya6, K Björklund-Bodegård7, T Ohkubo8, J Jeppesen9, C Torp-Pedersen9, E Dolan10, T Kuznetsova2, K Stolarz-Skrzypek11, V Tikhonoff12, S Malyutina13, E Casiglia12, Y Nikitin13, L Lind7, E Sandoya14, K Kawecka-Jaszcz11, J Filipovský15, Y Imai6, J Wang16, E O'Brien17, J A Staessen18.   

Abstract

Overweight clusters with high blood pressure (BP), but the independent contribution of both risk factors remains insufficiently documented. In a prospective population study involving 8467 participants (mean age 54.6 years; 47.0% women) randomly recruited from 10 populations, we studied the contribution of body mass index (BMI) to risk over and beyond BP, taking advantage of the superiority of ambulatory over conventional BP. Over 10.6 years (median), 1271 participants (15.0%) died and 1092 (12.9%), 637 (7.5%) and 443 (5.2%) experienced a fatal or nonfatal cardiovascular, cardiac or cerebrovascular event. Adjusted for sex and age, low BMI (<20.7 kg m(-2)) predicted death (hazard ratio (HR) vs average risk, 1.52; P<0.0001) and high BMI (> or = 30.9 kg m(-2)) predicted the cardiovascular end point (HR, 1.27; P=0.006). With adjustments including 24-h systolic BP, these HRs were 1.50 (P<0.001) and 0.98 (P=0.91), respectively. Across quartiles of the BMI distribution, 24-h and nighttime systolic BP predicted every end point (1.13 < or = standardized HR < or = 1.67; 0.046 < or = P<0.0001). The interaction between systolic BP and BMI was nonsignificant (P > or = .22). Excluding smokers removed the contribution of BMI categories to the prediction of mortality. In conclusion, BMI only adds to BP in risk stratification for mortality but not for cardiovascular outcomes. Smoking probably explains the association between increased mortality and low BMI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24430701     DOI: 10.1038/jhh.2013.145

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  43 in total

1.  Cardiovascular protection and blood pressure reduction: a meta-analysis.

Authors:  J A Staessen; J G Wang; L Thijs
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

2.  Smoking and blood pressure in 15 year olds in Dunedin, New Zealand.

Authors:  I M St George; S Williams; W R Stanton; P A Silva
Journal:  BMJ       Date:  1991-01-12

3.  Inverse relation between serum cotinine concentration and blood pressure in cigarette smokers.

Authors:  N L Benowitz; D S Sharp
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

4.  Ambulatory blood pressure of adults in Novosibirsk, Russia: interim report on a population study.

Authors:  T Kuznetsova; S Malyutina; E Pello; L Thijs; Y Nikitin; J A Staessen
Journal:  Blood Press Monit       Date:  2000 Oct-Dec       Impact factor: 1.444

5.  Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations.

Authors:  Tine W Hansen; Lutgarde Thijs; Yan Li; José Boggia; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Jørgen Jeppesen; Christian Torp-Pedersen; Eamon Dolan; Tatiana Kuznetsova; Katarzyna Stolarz-Skrzypek; Valérie Tikhonoff; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Edgardo Sandoya; Kalina Kawecka-Jaszcz; Yutaka Imai; Jiguang Wang; Hans Ibsen; Eoin O'Brien; Jan A Staessen
Journal:  Hypertension       Date:  2010-03-08       Impact factor: 10.190

6.  Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

7.  Body-mass index and mortality among 1.46 million white adults.

Authors:  Amy Berrington de Gonzalez; Patricia Hartge; James R Cerhan; Alan J Flint; Lindsay Hannan; Robert J MacInnis; Steven C Moore; Geoffrey S Tobias; Hoda Anton-Culver; Laura Beane Freeman; W Lawrence Beeson; Sandra L Clipp; Dallas R English; Aaron R Folsom; D Michal Freedman; Graham Giles; Niclas Hakansson; Katherine D Henderson; Judith Hoffman-Bolton; Jane A Hoppin; Karen L Koenig; I-Min Lee; Martha S Linet; Yikyung Park; Gaia Pocobelli; Arthur Schatzkin; Howard D Sesso; Elisabete Weiderpass; Bradley J Willcox; Alicja Wolk; Anne Zeleniuch-Jacquotte; Walter C Willett; Michael J Thun
Journal:  N Engl J Med       Date:  2010-12-02       Impact factor: 91.245

8.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

9.  Is the relationship between blood pressure and cardiovascular risk dependent on body mass index?

Authors:  F Cambien; J M Chretien; P Ducimetiere; L Guize; J L Richard
Journal:  Am J Epidemiol       Date:  1985-09       Impact factor: 4.897

Review 10.  Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis.

Authors:  Katherine M Flegal; Brian K Kit; Heather Orpana; Barry I Graubard
Journal:  JAMA       Date:  2013-01-02       Impact factor: 56.272

View more
  1 in total

1.  Prognostic Value of Ambulatory Blood Pressure in the Obese: The Ambulatory Blood Pressure-International Study.

Authors:  Paolo Palatini; Gianpaolo Reboldi; Lawrence J Beilin; Edoardo Casiglia; Kazuo Eguchi; Yutaka Imai; Kazuomi Kario; Takayoshi Ohkubo; Sante D Pierdomenico; Joseph E Schwartz; Lindon Wing; Paolo Verdecchia
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-10-05       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.